Association of Elevated Serum Tryptase with Cutaneous Photodamage and Skin Cancers

Abstract

<b><i>Introduction:</i></b> Mast cells and their major protein, the serine proteinase tryptase, can be involved in cutaneous photodamage and carcinogenesis. The serum test of tryptase (S-tryptase) measures total tryptase protein (active tryptase and inactive protryptases), and S-tryptase is elevated in a variety of diseases, for example, in mastocytosis and α-tryptasemia. <b><i>Objectives:</i></b> The objective of this study is to study whether S-tryptase is a marker of cutaneous photodamage and carcinogenesis. <b><i>Methods:</i></b> Adult subjects (<i>n</i> = 399, aged 21–79) evaluated to be at risk for skin cancers were recruited at the dermatological policlinic and examined for photodamage severity, mole count, actinic keratoses (AKs), skin cancers, and immunosuppression (IS). A blood sample was analyzed for S-tryptase using the ImmunoCAP® Tryptase fluoroenzymeimmunoassay. <b><i>Results:</i></b> There was no difference in S-tryptase between non-IS (<i>n</i> = 321) and IS (<i>n</i> = 78) subjects or between genders. S-tryptase correlated slightly to photodamage and AKs in 321 non-IS subjects, and this association can be related, in part, to the age of subjects. In 34 subjects, S-tryptase was elevated (≥13.5 ng/mL), and in 20 males, but not in 14 females, the photodamage level was significantly (<i>p</i> = 0.031) more severe than in 179 males with normal S-tryptase. In contrast, there were more frequently subjects (<i>n</i> = 12) with past or present skin cancer (basal or squamous cell carcinoma or melanoma) in 14 females with elevated S-tryptase than in 186 female controls. So far, no explanation has been found for the elevated S-tryptase. <b><i>Conclusion:</i></b> There are significant associations between elevated S-tryptase and skin carcinogenesis, but the molecular mechanisms are unclear and gender differences can exist.